Literature DB >> 13604607

[Experimental studies on the problem of rarity of tumor metastases in skeletal muscles].

B KORPASSY, F SZONYI, G BARADNAY.   

Abstract

Entities:  

Keywords:  ENCEPHALOMYELITIS/pathology; MUSCLES/neoplasms; NEOPLASMS/pathology

Mesh:

Year:  1958        PMID: 13604607

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN: 0301-1585


× No keyword cloud information.
  10 in total

1.  [New concepts of the mechanism of development of neoplastic metastases].

Authors:  B KORPASSY
Journal:  Sperimentale       Date:  1956 Jul-Aug

2.  [Results of intravenous implantation of inoculation neoplasms].

Authors:  K KARRER
Journal:  Wien Klin Wochenschr       Date:  1957-03-22       Impact factor: 1.704

3.  Examination of blood for tumor cells.

Authors:  A A SANDBERG; G E MOORE
Journal:  J Natl Cancer Inst       Date:  1957-07       Impact factor: 13.506

4.  Transplenic passage of tumour cell emboli.

Authors:  B KORPASSY; K KOVACS; T TIBOLDI
Journal:  Acta Morphol Acad Sci Hung       Date:  1954

5.  [Metastatic tumors in striated muscle; review and case report].

Authors:  C PRIOR
Journal:  Riv Anat Patol Oncol       Date:  1953-01

6.  [Experimental data on metastatic tumors of the ovary].

Authors:  G JAKI; K KOVACS; B KORPASSY
Journal:  Kiserl Orvostud       Date:  1953-05

7.  Transpulmonary passage of tumor cell emboli.

Authors:  I ZEIDMAN; J M BUSS
Journal:  Cancer Res       Date:  1952-10       Impact factor: 12.701

8.  Factors affecting the distribution of tumor metastases; experiments with V2 carcinoma of rabbits.

Authors:  D R COMAN; R B EISENBERG; M McCUTCHEON
Journal:  Cancer Res       Date:  1949-11       Impact factor: 12.701

9.  [Metastasis of malignant tumors to skeletal muscle].

Authors:  H CRONEMEYER
Journal:  Arch Geschwulstforsch       Date:  1952

10.  STUDIES BASED ON A MALIGNANT TUMOR OF THE RABBIT : III. INTRATESTICULAR TRANSPLANTATION AND CLINICAL COURSE OF THE DISEASE.

Authors:  W H Brown; L Pearce
Journal:  J Exp Med       Date:  1923-05-31       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.